SETTLEMENT AND COOPERATION AGREEMENTSettlement & Cooperation Agreement • December 14th, 2022 • Pasithea Therapeutics Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 14th, 2022 Company Industry JurisdictionThis Settlement and Cooperation Agreement (the “Agreement”) is made and entered into as of December 9, 2022, by and among Pasithea Therapeutics Corp. (the “Company”), on the one hand, and Concord IP2 Ltd., Elderhill Corporation, Leonite Capital LLC, Leonite Fund I, LP, Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, David Delaney, Avi Geller, and Eric Shahinian (collectively, the “Investor Group Parties”), on the other hand (each of the Company and the Investor Group Parties, a “Party” and collectively, the “Parties”).